DK1268522T3 - LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler - Google Patents

LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler

Info

Publication number
DK1268522T3
DK1268522T3 DK01933682T DK01933682T DK1268522T3 DK 1268522 T3 DK1268522 T3 DK 1268522T3 DK 01933682 T DK01933682 T DK 01933682T DK 01933682 T DK01933682 T DK 01933682T DK 1268522 T3 DK1268522 T3 DK 1268522T3
Authority
DK
Denmark
Prior art keywords
antagonists
drugs
preparation
well
hormone
Prior art date
Application number
DK01933682T
Other languages
English (en)
Inventor
Michael Bernd
Bernhard Kutscher
Eckhard Guenther
Peter Romeis
Thomas Reissmann
Thomas Beckers
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/525,007 external-priority patent/US6627609B1/en
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of DK1268522T3 publication Critical patent/DK1268522T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK01933682T 2000-03-14 2001-03-12 LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler DK1268522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/525,007 US6627609B1 (en) 1999-03-17 2000-03-14 LHRH antagonists having improved solubility properties
PCT/EP2001/002719 WO2001068676A2 (de) 2000-03-14 2001-03-12 Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel

Publications (1)

Publication Number Publication Date
DK1268522T3 true DK1268522T3 (da) 2009-01-12

Family

ID=24091545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01933682T DK1268522T3 (da) 2000-03-14 2001-03-12 LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler

Country Status (25)

Country Link
EP (1) EP1268522B1 (da)
JP (1) JP3805679B2 (da)
KR (1) KR100607396B1 (da)
CN (2) CN1443195A (da)
AT (1) ATE408619T1 (da)
AU (2) AU2001260110B2 (da)
BG (1) BG107121A (da)
BR (1) BR0109279A (da)
CA (1) CA2402193C (da)
DE (1) DE50114335D1 (da)
DK (1) DK1268522T3 (da)
ES (1) ES2312435T3 (da)
HR (1) HRP20020810A2 (da)
HU (1) HUP0300222A3 (da)
IL (1) IL151647A0 (da)
MX (1) MXPA02008870A (da)
NO (1) NO20024363L (da)
NZ (1) NZ521273A (da)
PL (1) PL357999A1 (da)
PT (1) PT1268522E (da)
RU (1) RU2248982C9 (da)
SK (1) SK14332002A3 (da)
UA (1) UA79070C2 (da)
WO (1) WO2001068676A2 (da)
ZA (1) ZA200207248B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100340572C (zh) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 新的lhrh拮抗剂
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
EP2252627B1 (en) 2008-01-24 2017-04-19 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
CN101597321B (zh) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
WO2010142060A1 (zh) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
US9492563B2 (en) 2012-10-30 2016-11-15 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
FR3024612B1 (fr) * 2014-08-04 2018-03-09 Alstom Transp Tech Module d'alimentation electrique d'un bloc moteur, systeme de traction et vehicule electrique associe
RU2585367C1 (ru) * 2014-11-05 2016-05-27 Наталья Владимировна Спиридонова Способ лечения бесплодия у женщин с миомой матки

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5300492A (en) 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
IL101074A (en) 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
DK0593491T3 (da) 1991-04-25 1997-03-17 Romano Deghenghi Luteiniseringshormonfrigørende hormonantagonistpeptider
US5698522A (en) 1992-12-04 1997-12-16 Abbott Laboratories 6-position modified decapeptide LHRH antagonists
EP0683792B1 (en) 1992-12-18 2001-09-26 Abbott Laboratories Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
IL108509A0 (en) 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
DE19544212A1 (de) 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
RU2248982C2 (ru) 2005-03-27
PT1268522E (pt) 2008-12-22
RU2248982C9 (ru) 2005-06-10
NO20024363L (no) 2002-11-13
CA2402193C (en) 2010-05-18
NO20024363D0 (no) 2002-09-12
HUP0300222A2 (hu) 2003-07-28
HUP0300222A3 (en) 2004-08-30
IL151647A0 (en) 2003-04-10
NZ521273A (en) 2005-01-28
JP3805679B2 (ja) 2006-08-02
DE50114335D1 (de) 2008-10-30
AU6011001A (en) 2001-09-24
ES2312435T3 (es) 2009-03-01
HRP20020810A2 (en) 2004-12-31
PL357999A1 (en) 2004-08-09
BR0109279A (pt) 2002-12-17
SK14332002A3 (sk) 2003-09-11
UA79070C2 (en) 2007-05-25
KR100607396B1 (ko) 2006-08-02
CN100500692C (zh) 2009-06-17
CN1876677A (zh) 2006-12-13
ATE408619T1 (de) 2008-10-15
JP2003535044A (ja) 2003-11-25
ZA200207248B (en) 2003-02-21
AU2001260110B2 (en) 2005-05-05
CN1443195A (zh) 2003-09-17
CA2402193A1 (en) 2002-09-09
EP1268522A2 (de) 2003-01-02
MXPA02008870A (es) 2003-06-24
KR20020083179A (ko) 2002-11-01
WO2001068676A2 (de) 2001-09-20
EP1268522B1 (de) 2008-09-17
WO2001068676A3 (de) 2002-10-24
BG107121A (bg) 2003-05-30

Similar Documents

Publication Publication Date Title
SE0001899D0 (sv) New compounds
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
CY1109463T1 (el) Πεπτιδια kdr και εμβολια που τα περιλαμβανουν
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
CY1105019T1 (el) Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
SE0001916D0 (sv) Novel formulation
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
MXPA02012015A (es) Ligandos de receptores para integrinas.
CY1105363T1 (el) Ν,ν΄-διυποκατεστημενες ενωσεις πιπepαζινης και η χρηση τους σαν αναλγητικα μεσα
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DE50212538D1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzoäcüfluoren-6-carbonsäurederivate als nmda-antagonisten
DE50304524D1 (de) Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole
UA38889A (uk) Лікувальний засіб "ліварекс" на основі диметоксіуреїдофосфорної кислоти
ATE361097T1 (de) Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp
ITUD20030196A1 (it) Procedimento per la preparazione di dosaggi farmaceutici contenenti molteplici principi attivi.